Ryan Zimmerman
Stock Analyst at BTIG
(4.51)
# 321
Out of 4,667 analysts
166
Total ratings
57.5%
Success rate
18.42%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $383 → $394 | $385.68 | +2.16% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $4.41 | +126.76% | 4 | Oct 18, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $518 → $535 | $541.82 | -1.26% | 16 | Oct 18, 2024 | |
| PEN Penumbra | Maintains: Buy | $224 → $234 | $239.20 | -2.17% | 15 | Oct 14, 2024 | |
| GMED Globus Medical | Maintains: Buy | $77 → $78 | $83.59 | -6.69% | 10 | Oct 14, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $85.50 | +23.98% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $22.93 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $109.27 | +15.31% | 7 | Oct 3, 2024 | |
| GEHC GE HealthCare Technologies | Upgrades: Buy | $100 | $84.90 | +17.79% | 2 | Sep 18, 2024 | |
| SOLV Solventum | Initiates: Neutral | n/a | $68.39 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $131 → $139 | $141.44 | -1.73% | 9 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $44.81 | +62.91% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $26.32 | +101.37% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $55 | $57.26 | -3.95% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.41 | +628.16% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.98 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.05 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.06 | +277.36% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.97 | +51.13% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.03 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $25.50 | +103.92% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.87 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $15.56 | +79.95% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $164.95 | +21.25% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $266.58 | +31.29% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $115.93 | +12.14% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $92.70 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $84.11 | +52.18% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $7.28 | +106.04% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $78.04 | +16.61% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $16.78 | +150.30% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $9.94 | +428.17% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.90 | - | 3 | Apr 2, 2020 |
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $385.68
Upside: +2.16%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $4.41
Upside: +126.76%
Intuitive Surgical
Oct 18, 2024
Maintains: Buy
Price Target: $518 → $535
Current: $541.82
Upside: -1.26%
Penumbra
Oct 14, 2024
Maintains: Buy
Price Target: $224 → $234
Current: $239.20
Upside: -2.17%
Globus Medical
Oct 14, 2024
Maintains: Buy
Price Target: $77 → $78
Current: $83.59
Upside: -6.69%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $85.50
Upside: +23.98%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $22.93
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $109.27
Upside: +15.31%
GE HealthCare Technologies
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $84.90
Upside: +17.79%
Solventum
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $68.39
Upside: -
Aug 28, 2024
Maintains: Buy
Price Target: $131 → $139
Current: $141.44
Upside: -1.73%
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $44.81
Upside: +62.91%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $26.32
Upside: +101.37%
Jul 15, 2024
Maintains: Buy
Price Target: $56 → $55
Current: $57.26
Upside: -3.95%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.41
Upside: +628.16%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.98
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.05
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.06
Upside: +277.36%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $3.97
Upside: +51.13%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $9.03
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $25.50
Upside: +103.92%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $18.87
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $15.56
Upside: +79.95%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $164.95
Upside: +21.25%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $266.58
Upside: +31.29%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $115.93
Upside: +12.14%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $92.70
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $84.11
Upside: +52.18%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $7.28
Upside: +106.04%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $78.04
Upside: +16.61%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $16.78
Upside: +150.30%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $9.94
Upside: +428.17%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $12.90
Upside: -